India Pesticides Q1 FY27: The Cheap Stock That's Losing Its Reason

India Pesticides has a trailing P/E of roughly 14.6x against an Indian chemicals industry average of about 21.9x. On paper, that looks like a discount. The question is whether the discount exists because the market is wrong or because the business just stopped doing what it was doing.

The Q1 FY27 numbers say the latter.

Consolidated revenue fell 8.5% year-over-year to ₹251.76 crore, down 5.5% from Q4 FY26. Net profit dropped 34.8% to ₹22.77 crore. The net profit margin narrowed to roughly 8.9%, down from 12.3% a year ago and 11.3% in the prior quarter. Cost of materials consumed rose to ₹185.12 crore even as revenue declined, which means the squeeze sits on the gross line - both softer volumes and input-cost pressure, not a one-off charge.

The street was pricing for something entirely different. Preview estimates had revenue in a ₹340-391 crore range and net profit between ₹43-55 crore. Those estimates were built by applying FY26's trailing growth rates to the Q1 FY26 base. The actual result missed the low end of revenue by nearly ₹88 crore. That is not a soft miss. That is the kind of print that suggests the entire estimation framework was built on the assumption that FY26 was a floor and Q1 FY27 would extend it.

The comparison set matters more than the absolute number

India Pesticides is a ₹17.75 billion market-cap company in a sector where the larger players are pulling away. Insecticides India posted Q1 FY27 revenue of ₹727 crore, up 5.2% year-over-year, with profit up 18.4%. PI Industries grew revenue 7% and profit 31% in the same quarter. Both peers expanded margins. India Pesticides shrank.

The agrochemicals subsector as a whole grew revenue barely 0.6% in Q1 FY27, the weakest growth reading among 11 subsectors in the broader Materials & Chemicals space, which posted a 17% median. So the industry headwind is real. But the peers found a way through it - and India Pesticides did not. When the sector is essentially flat and one name falls 8.5% while others grow 5-7%, the divergence is a quality signal, not a cyclical blip.

The input cost story is part of the picture. Raw material prices for agrochemicals rose 15-20% in early 2026, driven by West Asia geopolitical disruptions pushing up energy-linked feedstock costs. Other operators absorbed it or passed it through. India Pesticides could not. The material cost line went up while revenue went down, which tells you the pricing power wasn't there this quarter.

The trap of the trailing multiple

The 14.6x trailing P/E looks cheap only because it's calculated on FY26 earnings of ₹120 crore - a banner year with 27.9% revenue growth and 45.8% profit growth. That is a classic base effect working in reverse. The trailing multiple is backward-looking, and it tells you nothing about the trajectory the just-completed quarter has established.

Annualizing Q1's ₹22.77 crore profit gives roughly ₹91 crore for the year, which would push the forward P/E into the mid-to-high 19x range. If margins stay compressed, it could go higher. At that level, the stock is no longer cheaper than the sector average - it's at the sector average, just without the growth that other average-valued peers are posting.

The 12-month analyst target range of ₹190-211 from Uniresearch was set before this quarter. That range implied roughly 20-33% upside from the pre-earnings price of ₹159. A quarter that misses revenue estimates by a margin larger than most smallcaps' full-year growth does not leave that target range intact.

What to watch

The agrochemicals industry is expected to grow 6-8% in FY27 according to CareEdge Ratings. That is a slow recovery, not a surge. India Pesticides entering that environment with a contracting topline and eroding margins means the next two quarters are the test. If input costs ease and volumes recover, Q2 could show stabilization. If raw material inflation persists and the company still cannot raise prices, the margin compression widens.

The stock also carried a ₹2.29 crore insurance settlement gain in Q1 FY26's other income. Even adjusting for that one-off, profit is still down roughly 31% year-over-year. The deterioration is structural, not cosmetic.

India Pesticides is a ₹17.75 billion company. It is not too large to recover from a bad quarter, and it is not too small for the factor stack to matter. The factor stack right now says: valuation that looks cheap on a stale base, growth that turned negative, profitability that compressed, and a peer comparison where the stock is losing relative position on every measurable axis. No stock is absolutely cheap. The discount is a mirror, and the reflection has changed.